Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-11-06
2007-11-06
Nguyen, Bao-Thuy L. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007920, C435S007940, C435S960000, C435S971000, C436S506000, C436S507000, C436S518000, C436S538000, C424S130100
Reexamination Certificate
active
10276919
ABSTRACT:
The present invention provides a process of screening patients for atopic dermatitis. The process includes the step of determining, in sera of the patient, the presence of antibodies against nuclear antigens such as transcription co-activator p75, wherein the presence of such antibodies indicates atopic dermatitis. The screening process can be used to detect atopic dermatitis in patients suffering from other conditions such as asthma or interstitial cystitis.
REFERENCES:
patent: 2005/0042631 (2005-02-01), Ge
Quinti, et al., “Circulating IgG autoantibodies to IgE in atopic syndromes”,J. Allergy Clin. Immunol. 77: 586-594 (1986).
Tada, et al., “Antinuclear Antibodies in Patients with Atopic Dermatitis and Severe Facial Lesions”,Dermatology 189: 38-40 (1994).
Cooper, “Atopic Dermatitis: Recent Trends in Pathogenesis and Therapy”,J. Invest. Dermatol. 102: 128-137 (1994).
Ochs, et al. “Autoantibodies in Interstitial Cystitis”,J. Urol. 151: 587-592 (1994).
Radic, et al., “Genetic and Structural Evidence for Antigen Selection of Anti-DNA Antibodies”,Annu. Rev. Immunol. 12: 487-520 (1994).
Konstantinov, et al., “Autoantibodies to Nuclear Envelope Antigens in Chronic Fatigue Syndrome”,J. Clin. Invest. 98: 1888-1896 (1996).
Marone, et al., “The anti-IgE/anti-FcεRlα autoantibody network in allergic and autoimmune diseases”,Clinical and Experimental Allergy 29: 17-27 (1999).
Valenta, et al., “Autoallergy: A Pathogenic Factor in Atopic Dermatitis?”,Curr. Prob. Dermatol. 28: 45-50 (1999).
Seiberler, et al., “Characterization of IgE-Reactive Autoantigens in Atopic Dermatitis”,Int. Arch. Allergy Immunol. 120: 108-116 (1999).
Tan, “Autoantibodies in Diagnosis and in Identifying Autoantigens”,The Immunologist 7: 85-92 (1999).
Beltrani, “Atopic dermatitis: An update”,J. Allergy Clin. Immunol. 104: S85-S86 (1999).
Beltrani, “The clinical spectrum of atopic dermatitis”,J. Allergy Clin. Immunol. 104: S87-S98 (1999).
Leung, “Pathogenesis of atopic dermatitis”,J. Allergy Clin. Immunol. 104: S99-S108 (1999).
Hayashi, et al., “Detection of anti-IgE and anti-FcεRI α chain auto-antibodies in patients with atopic dermatitis”,Allergology International 49: 47-54 (2000).
Ochs, et al., “Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions”,J. Allergy Clin. Immunol. 105: 1211-1220 (2000).
Muro, “Autoantibodies in atopic dermatitis”,J. Dermatol. Science 25: 171-178 (2001).
Hanifin et al., “Diagnostic features of atopic dermatitis.”Acta Dermatovener(Stockholm)Suppl1980; 92:44-47.
Taniguchi, et al., “Positive antinuclear antibody in atopic dermatitis.”Acta Derm Venereo(Stockh)Suppl1992:176:62-64.
Gillenwater et al., “Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda Maryland Aug. 28-29, 1987,”J Urol1988; 140:203-206.
Koziol et al., “The natural history of interstitial cystitis: a survey of 374 patients,”J Urol1993; 149:465-469.
Ochs et al.,Interstitial Cystitis, 1997, pp. 47-52.
Valenta et al., “Immunoglobulin E response to human proteins in atopic dermatitis,”J Invest Dermatol1996; 107:203-208.
Ge et al., “Purification, cloning, and characterization of a human co-activator, PC4, that mediates transcriptional activation of Class II genes,”Cell1994; 78;513-522.
Ge et al., “Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanisms of transcriptional activation,”EMBO J.1998; 17:6723-6729.
Ochs et al., “6thInternational Congress on Cell Biology and 36thAmerican Society for Cell Biology Annual meeting,”Molec Biol Cell1996; 6.75a Suppl.
Singh et al., “The role of the p53 protein in the selective vulnerability of the inner retina to transient ischemia,”Invest Ophthalmol Vis Sci1998; 39(11):2132-9.
Tan, “Autoantibodies in pathology and cell biology,”Cell1991; 67:841-842.
Forrest et al., “Identifying genes predisposing to atopic eczema,”J Allergy Clin Immunol1999; 104:1066-1070.
Fagerholm et al., “Atopic cataract: changes in the lens epithelium and subcapsular cortex,”Graefes Arch Clin Ophthamol. 1984; 221:149-152.
Nakano et al., “Ocular complications of atopic dermatitis,”J Jpn Ophthalmaol Soc1997; 101:64-68 (abstract).
Chan Edward K. L.
Muro Yoshinao
Ochs Robert L.
Tan Eng M.
Fitting Thomas
McCarthy Michael J.
Nguyen Bao-Thuy L.
The Scripps Research Institute
Wang Hugh
LandOfFree
Screening process for atopic dermatitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening process for atopic dermatitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening process for atopic dermatitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3818626